| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |